APO Research
Talk to an analyst

APO RESEARCH · REPORT

Potassium-Sparing Diuretic

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Potassium-Sparing Diuretic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025193 pages

Choose your research edition.

Industry ResearchPotassium-Sparing Diuretic Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Potassium-Sparing Diuretic Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Potassium-Sparing Diuretic Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Potassium-Sparing Diuretic Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Potassium-Sparing Diuretic Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Potassium-Sparing Diuretic market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Potassium-Sparing Diuretic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Potassium-Sparing Diuretic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Potassium-Sparing Diuretic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Potassium-Sparing Diuretic is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Potassium-Sparing Diuretic include Teva, Novartis, Merck, Pfizer, Bayer, Validus Pharmaceuticals, CMP Pharma, Centaur Pharmaceuticals and Boehringer Ingelheim, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Potassium-Sparing Diuretic market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Potassium-Sparing Diuretic and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Potassium-Sparing Diuretic sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Potassium-Sparing Diuretic market size, projected growth trends, production technologies, key applications, and end-use industries.

Potassium-Sparing Diuretic Segment by Company

Teva

Novartis

Merck

Pfizer

Bayer

Validus Pharmaceuticals

CMP Pharma

Centaur Pharmaceuticals

Boehringer Ingelheim

Amneal Pharmaceuticals

Accord Healthcare

Potassium-Sparing Diuretic Segment by Type

Amiloride

Triamterene

Spironolactone

Eplerenone

Others

Potassium-Sparing Diuretic Segment by Application

Heart Failure

Hypertension

Liver Cirrhosis

Edema

Others

Potassium-Sparing Diuretic Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Potassium-Sparing Diuretic market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Potassium-Sparing Diuretic and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Potassium-Sparing Diuretic.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Potassium-Sparing Diuretic market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Potassium-Sparing Diuretic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Potassium-Sparing Diuretic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Potassium-Sparing Diuretic in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Potassium-Sparing Diuretic Industry Trends Table 2. Potassium-Sparing Diuretic Industry Drivers Table 3. Potassium-Sparing Diuretic Industry Opportunities and Challenges Table 4. Potassium-Sparing Diuretic Industry Restraints Table 5. Global Potassium-Sparing Diuretic Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Potassium-Sparing Diuretic Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Potassium-Sparing Diuretic Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Potassium-Sparing Diuretic Sales Market Share by Manufacturers Table 9. Global Potassium-Sparing Diuretic Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Potassium-Sparing Diuretic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Potassium-Sparing Diuretic Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Potassium-Sparing Diuretic Manufacturers, Product Type & Application Table 13. Global Potassium-Sparing Diuretic Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Potassium-Sparing Diuretic by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Amiloride Table 17. Major Manufacturers of Triamterene Table 18. Major Manufacturers of Spironolactone Table 19. Major Manufacturers of Eplerenone Table 20. Major Manufacturers of Others Table 21. Global Potassium-Sparing Diuretic Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Potassium-Sparing Diuretic Sales by Type (2021-2026) & (K Units) Table 23. Global Potassium-Sparing Diuretic Sales by Type (2027-2032) & (K Units) Table 24. Global Potassium-Sparing Diuretic Sales Market Share by Type (2021-2026) Table 25. Global Potassium-Sparing Diuretic Sales Market Share by Type (2027-2032) Table 26. Global Potassium-Sparing Diuretic Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Potassium-Sparing Diuretic Revenue by Type (2021-2026) & (K Units) Table 28. Global Potassium-Sparing Diuretic Revenue by Type (2027-2032) & (K Units) Table 29. Global Potassium-Sparing Diuretic Revenue Market Share by Type (2021-2026) Table 30. Global Potassium-Sparing Diuretic Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Heart Failure Table 32. Major Manufacturers of Hypertension Table 33. Major Manufacturers of Liver Cirrhosis Table 34. Major Manufacturers of Edema Table 35. Major Manufacturers of Others Table 36. Global Potassium-Sparing Diuretic Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Potassium-Sparing Diuretic Sales by Application (2021-2026) & (K Units) Table 38. Global Potassium-Sparing Diuretic Sales by Application (2027-2032) & (K Units) Table 39. Global Potassium-Sparing Diuretic Sales Market Share by Application (2021-2026) Table 40. Global Potassium-Sparing Diuretic Sales Market Share by Application (2027-2032) Table 41. Global Potassium-Sparing Diuretic Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Potassium-Sparing Diuretic Revenue by Application (2021-2026) & (K Units) Table 43. Global Potassium-Sparing Diuretic Revenue by Application (2027-2032) & (K Units) Table 44. Global Potassium-Sparing Diuretic Revenue Market Share by Application (2021-2026) Table 45. Global Potassium-Sparing Diuretic Revenue Market Share by Application (2027-2032) Table 46. Global Potassium-Sparing Diuretic Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Potassium-Sparing Diuretic Sales by Region (2021-2026) & (K Units) Table 48. Global Potassium-Sparing Diuretic Sales Market Share by Region (2021-2026) Table 49. Global Potassium-Sparing Diuretic Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Potassium-Sparing Diuretic Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Potassium-Sparing Diuretic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Potassium-Sparing Diuretic Sales by Country (2021-2026) & (K Units) Table 53. North America Potassium-Sparing Diuretic Sales by Country (2027-2032) & (K Units) Table 54. Europe Potassium-Sparing Diuretic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Potassium-Sparing Diuretic Sales by Country (2021-2026) & (K Units) Table 56. Europe Potassium-Sparing Diuretic Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Potassium-Sparing Diuretic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Potassium-Sparing Diuretic Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Potassium-Sparing Diuretic Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Potassium-Sparing Diuretic Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Potassium-Sparing Diuretic Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Potassium-Sparing Diuretic Sales by Country (2027-2032) & (K Units) Table 63. Global Potassium-Sparing Diuretic Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Potassium-Sparing Diuretic Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Potassium-Sparing Diuretic Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Potassium-Sparing Diuretic Revenue Market Share by Region (2021-2026) Table 67. Global Potassium-Sparing Diuretic Revenue Market Share by Region (2027-2032) Table 68. Teva Company Information Table 69. Teva Business Overview Table 70. Teva Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teva Potassium-Sparing Diuretic Product Portfolio Table 72. Teva Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Novartis Potassium-Sparing Diuretic Product Portfolio Table 77. Novartis Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merck Potassium-Sparing Diuretic Product Portfolio Table 82. Merck Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Pfizer Potassium-Sparing Diuretic Product Portfolio Table 87. Pfizer Recent Development Table 88. Bayer Company Information Table 89. Bayer Business Overview Table 90. Bayer Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Bayer Potassium-Sparing Diuretic Product Portfolio Table 92. Bayer Recent Development Table 93. Validus Pharmaceuticals Company Information Table 94. Validus Pharmaceuticals Business Overview Table 95. Validus Pharmaceuticals Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Validus Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio Table 97. Validus Pharmaceuticals Recent Development Table 98. CMP Pharma Company Information Table 99. CMP Pharma Business Overview Table 100. CMP Pharma Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. CMP Pharma Potassium-Sparing Diuretic Product Portfolio Table 102. CMP Pharma Recent Development Table 103. Centaur Pharmaceuticals Company Information Table 104. Centaur Pharmaceuticals Business Overview Table 105. Centaur Pharmaceuticals Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Centaur Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio Table 107. Centaur Pharmaceuticals Recent Development Table 108. Boehringer Ingelheim Company Information Table 109. Boehringer Ingelheim Business Overview Table 110. Boehringer Ingelheim Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Boehringer Ingelheim Potassium-Sparing Diuretic Product Portfolio Table 112. Boehringer Ingelheim Recent Development Table 113. Amneal Pharmaceuticals Company Information Table 114. Amneal Pharmaceuticals Business Overview Table 115. Amneal Pharmaceuticals Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Amneal Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio Table 117. Amneal Pharmaceuticals Recent Development Table 118. Accord Healthcare Company Information Table 119. Accord Healthcare Business Overview Table 120. Accord Healthcare Potassium-Sparing Diuretic Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Accord Healthcare Potassium-Sparing Diuretic Product Portfolio Table 122. Accord Healthcare Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Potassium-Sparing Diuretic Distributors List Table 126. Potassium-Sparing Diuretic Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Potassium-Sparing Diuretic Product Image Figure 2. Global Potassium-Sparing Diuretic Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Potassium-Sparing Diuretic Market Size (2021-2032) & (US$ Million) Figure 4. Global Potassium-Sparing Diuretic Sales (2021-2032) & (K Units) Figure 5. Global Potassium-Sparing Diuretic Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Potassium-Sparing Diuretic Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Amiloride Image Figure 9. Triamterene Image Figure 10. Spironolactone Image Figure 11. Eplerenone Image Figure 12. Others Image Figure 13. Global Potassium-Sparing Diuretic Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Potassium-Sparing Diuretic Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Potassium-Sparing Diuretic Sales Market Share by Type (2021-2032) Figure 16. Global Potassium-Sparing Diuretic Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Potassium-Sparing Diuretic Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Potassium-Sparing Diuretic Revenue Market Share by Type (2021-2032) Figure 19. Heart Failure Image Figure 20. Hypertension Image Figure 21. Liver Cirrhosis Image Figure 22. Edema Image Figure 23. Others Image Figure 24. Global Potassium-Sparing Diuretic Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Potassium-Sparing Diuretic Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Potassium-Sparing Diuretic Sales Market Share by Application (2021-2032) Figure 27. Global Potassium-Sparing Diuretic Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Potassium-Sparing Diuretic Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Potassium-Sparing Diuretic Revenue Market Share by Application (2021-2032) Figure 30. North America Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Potassium-Sparing Diuretic Sales Market Share by Country (2021-2032) Figure 32. U.S. Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Potassium-Sparing Diuretic Sales Market Share by Country (2021-2032) Figure 37. Germany Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Potassium-Sparing Diuretic Sales Market Share by Country (2021-2032) Figure 44. China Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Potassium-Sparing Diuretic Sales Market Share by Country (2021-2032) Figure 52. Brazil Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Potassium-Sparing Diuretic Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Potassium-Sparing Diuretic Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Potassium-Sparing Diuretic Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Potassium-Sparing Diuretic Revenue (2021-2032) & (US$ Million) Figure 63. North America Potassium-Sparing Diuretic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Potassium-Sparing Diuretic Revenue (2021-2032) & (US$ Million) Figure 65. Europe Potassium-Sparing Diuretic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Potassium-Sparing Diuretic Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Potassium-Sparing Diuretic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Potassium-Sparing Diuretic Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Potassium-Sparing Diuretic Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Potassium-Sparing Diuretic Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Potassium-Sparing Diuretic Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Amiloride
  • Triamterene
  • Spironolactone
  • Eplerenone
  • Others
Applications
  • Heart Failure
  • Hypertension
  • Liver Cirrhosis
  • Edema
  • Others
Companies covered
  • Teva
  • Novartis
  • Merck
  • Pfizer
  • Bayer
  • Validus Pharmaceuticals
  • CMP Pharma
  • Centaur Pharmaceuticals
  • Boehringer Ingelheim
  • Amneal Pharmaceuticals
  • Accord Healthcare

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Potassium-Sparing Diuretic Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Potassium-Sparing Diuretic Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Potassium-Sparing Diuretic Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Potassium-Sparing Diuretic Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Potassium-Sparing Diuretic Market Dynamics
  1. 2.1 Potassium-Sparing Diuretic Industry Trends
  2. 2.2 Potassium-Sparing Diuretic Industry Drivers
  3. 2.3 Potassium-Sparing Diuretic Industry Opportunities and Challenges
  4. 2.4 Potassium-Sparing Diuretic Industry Restraints
3 Potassium-Sparing Diuretic Market by Manufacturers
  1. 3.1 Global Potassium-Sparing Diuretic Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Potassium-Sparing Diuretic Sales by Manufacturers (2021-2026)
  3. 3.3 Global Potassium-Sparing Diuretic Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Potassium-Sparing Diuretic Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Potassium-Sparing Diuretic Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Potassium-Sparing Diuretic Manufacturers, Product Type & Application
  7. 3.7 Global Potassium-Sparing Diuretic Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Potassium-Sparing Diuretic Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Potassium-Sparing Diuretic Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Potassium-Sparing Diuretic Tier 1, Tier 2, and Tier 3
4 Potassium-Sparing Diuretic Market by Type
  1. 4.1 Potassium-Sparing Diuretic Type Introduction
  2. 4.1.1 Amiloride
  3. 4.1.2 Triamterene
  4. 4.1.3 Spironolactone
  5. 4.1.4 Eplerenone
  6. 4.1.5 Others
  7. 4.2 Global Potassium-Sparing Diuretic Sales by Type
  8. 4.2.1 Global Potassium-Sparing Diuretic Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Potassium-Sparing Diuretic Sales by Type (2021-2032)
  10. 4.2.3 Global Potassium-Sparing Diuretic Sales Market Share by Type (2021-2032)
  11. 4.3 Global Potassium-Sparing Diuretic Revenue by Type
  12. 4.3.1 Global Potassium-Sparing Diuretic Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Potassium-Sparing Diuretic Revenue by Type (2021-2032)
  14. 4.3.3 Global Potassium-Sparing Diuretic Revenue Market Share by Type (2021-2032)
5 Potassium-Sparing Diuretic Market by Application
  1. 5.1 Potassium-Sparing Diuretic Application Introduction
  2. 5.1.1 Heart Failure
  3. 5.1.2 Hypertension
  4. 5.1.3 Liver Cirrhosis
  5. 5.1.4 Edema
  6. 5.1.5 Others
  7. 5.2 Global Potassium-Sparing Diuretic Sales by Application
  8. 5.2.1 Global Potassium-Sparing Diuretic Sales by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Potassium-Sparing Diuretic Sales by Application (2021-2032)
  10. 5.2.3 Global Potassium-Sparing Diuretic Sales Market Share by Application (2021-2032)
  11. 5.3 Global Potassium-Sparing Diuretic Revenue by Application
  12. 5.3.1 Global Potassium-Sparing Diuretic Revenue by Application (2021 VS 2025 VS 2032)
  13. 5.3.2 Global Potassium-Sparing Diuretic Revenue by Application (2021-2032)
  14. 5.3.3 Global Potassium-Sparing Diuretic Revenue Market Share by Application (2021-2032)
6 Global Potassium-Sparing Diuretic Sales by Region
  1. 6.1 Global Potassium-Sparing Diuretic Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Potassium-Sparing Diuretic Sales by Region (2021-2032)
  3. 6.2.1 Global Potassium-Sparing Diuretic Sales by Region (2021-2026)
  4. 6.2.2 Global Potassium-Sparing Diuretic Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Potassium-Sparing Diuretic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Potassium-Sparing Diuretic Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Potassium-Sparing Diuretic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Potassium-Sparing Diuretic Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Potassium-Sparing Diuretic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Potassium-Sparing Diuretic Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Potassium-Sparing Diuretic Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Potassium-Sparing Diuretic Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Potassium-Sparing Diuretic Revenue by Region
  1. 7.1 Global Potassium-Sparing Diuretic Revenue by Region
  2. 7.1.1 Global Potassium-Sparing Diuretic Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Potassium-Sparing Diuretic Revenue by Region (2021-2026)
  4. 7.1.3 Global Potassium-Sparing Diuretic Revenue by Region (2027-2032)
  5. 7.1.4 Global Potassium-Sparing Diuretic Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Potassium-Sparing Diuretic Revenue (2021-2032)
  8. 7.2.2 North America Potassium-Sparing Diuretic Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Potassium-Sparing Diuretic Revenue (2021-2032)
  11. 7.3.2 Europe Potassium-Sparing Diuretic Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Potassium-Sparing Diuretic Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Potassium-Sparing Diuretic Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Potassium-Sparing Diuretic Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Potassium-Sparing Diuretic Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva
  2. 8.1.1 Teva Company Information
  3. 8.1.2 Teva Business Overview
  4. 8.1.3 Teva Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Potassium-Sparing Diuretic Product Portfolio
  6. 8.1.5 Teva Recent Developments
  7. 8.2 Novartis
  8. 8.2.1 Novartis Company Information
  9. 8.2.2 Novartis Business Overview
  10. 8.2.3 Novartis Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novartis Potassium-Sparing Diuretic Product Portfolio
  12. 8.2.5 Novartis Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Potassium-Sparing Diuretic Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Potassium-Sparing Diuretic Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Bayer
  26. 8.5.1 Bayer Company Information
  27. 8.5.2 Bayer Business Overview
  28. 8.5.3 Bayer Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Bayer Potassium-Sparing Diuretic Product Portfolio
  30. 8.5.5 Bayer Recent Developments
  31. 8.6 Validus Pharmaceuticals
  32. 8.6.1 Validus Pharmaceuticals Company Information
  33. 8.6.2 Validus Pharmaceuticals Business Overview
  34. 8.6.3 Validus Pharmaceuticals Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Validus Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio
  36. 8.6.5 Validus Pharmaceuticals Recent Developments
  37. 8.7 CMP Pharma
  38. 8.7.1 CMP Pharma Company Information
  39. 8.7.2 CMP Pharma Business Overview
  40. 8.7.3 CMP Pharma Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 CMP Pharma Potassium-Sparing Diuretic Product Portfolio
  42. 8.7.5 CMP Pharma Recent Developments
  43. 8.8 Centaur Pharmaceuticals
  44. 8.8.1 Centaur Pharmaceuticals Company Information
  45. 8.8.2 Centaur Pharmaceuticals Business Overview
  46. 8.8.3 Centaur Pharmaceuticals Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Centaur Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio
  48. 8.8.5 Centaur Pharmaceuticals Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Potassium-Sparing Diuretic Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
  55. 8.10 Amneal Pharmaceuticals
  56. 8.10.1 Amneal Pharmaceuticals Company Information
  57. 8.10.2 Amneal Pharmaceuticals Business Overview
  58. 8.10.3 Amneal Pharmaceuticals Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Amneal Pharmaceuticals Potassium-Sparing Diuretic Product Portfolio
  60. 8.10.5 Amneal Pharmaceuticals Recent Developments
  61. 8.11 Accord Healthcare
  62. 8.11.1 Accord Healthcare Company Information
  63. 8.11.2 Accord Healthcare Business Overview
  64. 8.11.3 Accord Healthcare Potassium-Sparing Diuretic Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Accord Healthcare Potassium-Sparing Diuretic Product Portfolio
  66. 8.11.5 Accord Healthcare Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Potassium-Sparing Diuretic Value Chain Analysis
  2. 9.1.1 Potassium-Sparing Diuretic Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Potassium-Sparing Diuretic Production Mode & Process
  6. 9.2 Potassium-Sparing Diuretic Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Potassium-Sparing Diuretic Distributors
  9. 9.2.3 Potassium-Sparing Diuretic Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst